Showing 1631-1640 of 4063 results for "".
- EyePoint Pharmaceuticals Announces First Patient Dosed in Phase 2 DAVIO 2 Clinical Trial of EYP-1901 for the Maintenance Treatment of Wet AMDhttps://modernod.com/news/eyepoint-pharmaceuticals-announces-first-patient-dosed-in-phase-2-davio-2-clinical-trial-of-eyp-1901-for-the-maintenance-treatment-of-wet-amd/2481005/EyePoint Pharmaceuticals, Inc., announced that the first patient has been dosed in the Phase 2 Durasert® and Vorolanib in Ophthalmology 2 (DAVIO 2) clinical trial of EYP-1901, an investigational sustained delivery antivascular endothelial growth factor (anti-VEGF) treatment for wet
- Trump Signs $2 Trillion Coronavirus Stimulus Packagehttps://modernod.com/news/house-passes-2-trillion-coronavirus-stimulus-package/2477476/The House quickly passed a $2 trillion stimulus package in a voice vote, and President Trump signed it into law on Friday. The bill, which pass
- Bausch + Lomb Introduces Preservision AREDS 2 Formula Minigel Eye Vitaminshttps://modernod.com/news/bausch-lomb-introduces-preservision-areds-2-formula-minigel-eye-vitamins/2477024/Bausch + Lomb announced the U.S. launch of PreserVision AREDS 2 Formula minigel eye vitamins. The new minigels will replace the currently offered PreserVision AREDS 2 Formula soft gels, offering patients an easier-to-swallow option as compared to the original AREDS 2 soft gels. PreserVision AREDS
- Two New Drug Classes Tied to Better Survival in Type 2 Diabeteshttps://modernod.com/news/two-new-drug-classes-tied-to-better-survival-in-type-2-diabetes/2480222/Patients with type 2 diabetes who did not achieve adequate glycemic control with metformin had improved survival during follow-up if they received add-on therapy with a sodium-glucose cotransporter 2 (SGLT-2) inhibitor or a glucagon-like peptide 1 (GLP-1) agonist rather than a dipeptidyl peptidas
- Quantel Medical Receives FDA Approval for the Vitra 2 Laser for Retinal Photocoagulationhttps://modernod.com/news/quantel-medical-receives-fda-approval-for-the-vitra-2-laser-for-retinal-photocoagulation/2477148/Quantel Medical announced that it has received approval from the FDA for the Vitra 2 photocoagulator. The Vitra 2 includes all the key elements of the Vitra photocoagulator and features a wide a range of improv
- Quantel Medical Introduces Vitra 2: Retinal Photocoagulation Simplifiedhttps://modernod.com/news/quantel-medical-introduces-vitra-2-retinal-photocoagulation-simplified/2480043/Quantel Medical said it has reinvented its flagship 532nm green photocoagulator with the introduction of the Vitra 2. The Vitra 2 features a new generation of optimized laser cavity with an increased max power
- The Vision Council Announces Dates for the 2021 Virtual Executive Summit: January 26–28, 2021https://modernod.com/news/the-vision-council-announces-dates-for-the-2021-virtual-executive-summit-january-26-28-2021/2478440/The Vision Council today announces that the
- Ocugen Completes Dosing of Subjects with Stargardt Disease in Cohort 2 of Phase 1/2 GARDian Clinical Trial of OCU410ST Gene Therapyhttps://modernod.com/news/ocugen-completes-dosing-of-subjects-with-stargardt-disease-in-cohort-2-of-phase-12-gardian-clinical-trial-of-ocu410st-gene-therapy/2482280/Ocugen announced that dosing is complete in the second cohort of its phase 1/2 GARDian clinical trial for OCU410ST (AAV-hRORA)—a modifier gene therapy candidate being developed for Stargardt disease as a one-time treatment. "The completion of dosing for Cohort 2 par
- EyePoint Pharmaceuticals Announces Positive Topline Data from the Phase 2 DAVIO 2 Trial of EYP-1901 in Wet AMDhttps://modernod.com/news/eyepoint-pharmaceuticals-announces-positive-topline-data-from-the-phase-2-davio-2-trial-of-eyp-1901-in-wet-amd/2481990/In a phase 2 study, EyePoint Pharmaceuticals’ wet AMD drug candidate demonstrated noninferiority to Eylea—with a less frequent dosing regimen. EyePoint leadership said the sustained-release implant could represent a 'paradigm-altering maintenance treatment' for patients with w
- Nidek Launches Retina Scan Duo 2 OCT/Fundus Camerahttps://modernod.com/news/nidek-launches-retina-scan-duotm-2-octfundus-camera/2480323/Nidek has announced the launch of the Retina Scan Duo 2, a combined OCT and fundus camera system. The Retina Scan Duo 2 incorporates new features designed to enhance screening and clinical efficiency, in addition to user-friendly features that were incorporated from the previous model.<